GlassScriptPhysician profile
Laura K Ganger
NPI 1568671535
$3,565.92
in general payments reported to CMS, 2019-2025
22 companies · $452 in 2025
The $452 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $475 · 2020: $313 · 2021: $375 · 2022: $518 · 2023: $850 · 2024: $583 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,705 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,704.72 |
| Education | $179.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,127.52 | 2019-2025 | Tremfya |
| Abbvie INC. | $840.26 | 2020-2025 | |
| Galderma Laboratories, L.P. | $345.27 | 2019-2023 | Oracea, Aklief, Epsolay |
| Sun Pharmaceutical Industries INC. | $292.08 | 2022-2025 | Absorica Ld, Winlevi |
| Pfizer INC. | $241.01 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $140.84 | 2019-2023 | Libtayo |
| Novartis Pharmaceuticals Corporation | $95.40 | 2019-2025 | |
| Arcutis Biotherapeutics, INC. | $75.40 | 2023-2025 | Zoryve |
| Allergan, INC. | $75.28 | 2019-2022 | |
| Incyte Corporation | $49.22 | 2021 | |
| Leo Pharma INC. | $45.99 | 2020-2025 | Anzupgo |
| Ucb, INC. | $42.66 | 2021 | |
| Kerecis Limited | $36.11 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Sandoz INC. | $33.06 | 2024 | Hyrimoz |
| Almirall LLC | $21.86 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $19.77 | 2024 | Sotyktu |
| Biofrontera INC. | $16.90 | 2024 | Xepi, Bf-Rhodoled, Rhodoled Xl |
| Genzyme Corporation | $16.57 | 2019 | |
| Merz North America, INC. | $16.18 | 2023 | |
| Merck Sharp & Dohme LLC | $12.65 | 2019 | |
| Sensus Healthcare, INC. | $11.92 | 2019 | |
| Epi Health, LLC | $9.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Ganger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.